Conventional cancer therapies, such as chemotherapy, surgery, and radiation, cannot target and destroy every metastatic cancer cell in a patient's body. Dr. Michael Har-Noy, founder and CEO of Immunovative Therapies Ltd, a biotech company in Israel, says that a patient's natural immunity, if conditioned properly, may be able to do this. Dr. Michael Har-Noy indicates that if one could somehow condition a patient's immune response so that it could find and eradicate malignant cells, an actual complete cure of the disease may be possible.
Over the past several years, Dr. Michael Har-Noy has developed a proprietary treatment he has termed the “Mirror EffectTM. The Mirror EffectTM technology is unique in that it both empowers a patient's immune response to target malignant cells and disrupts the tumor's ability to evade this response. The creation of the Mirror EffectTM and the development of the drugs that utilize it have the capacity to create an entire new field of oncology. Dr. Michael Har-Noy goes on to say that patenting and marketing these therapies could be both tremendously beneficial to cancer patients and immensely profitable for a company.
Dr. Michael Har-Noy has been working with his patent lawyers to construct a portfolio that protects the immense scope, depth, and detail of the Mirror EffectTM and outlines its use to condition a patient's immune system to fight some of the most refractory conditions described in the medical literature. Dr. Michael Har-Noy notes that the patent portfolio he is creating entails not only protection of his company's drugs and synthesizing methods but also has the potential to spawn an entirely new industry based on manipulating the human immune response.
Ultimately, Dr. Michael Har-Noy's patent portfolio will probably start a new field of oncologic therapy and radically alter the way malignancies are treated. Patent attorneys have compared potential impact of Dr. Michael Har-Noy's portfolio to that of the double-clicking of a mouse on a user interface on a computer screen. This double-clicking technology formed the foundation of the multi-billion dollar internet advertising industry. Dr. Michael Har-Noy believes his new technology will introduce an entirely new field of oncology and forever change the way cancer is treated, and that his Mirror EffectTM idea will therefore prove to be of virtually limitless value.